Literature DB >> 68399

Cyclophosphamide and malignancy.

H C Puri, R A Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 68399     DOI： 10.1016/s0140-6736(77)91336-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Plasma cell leukemia following treatment with radiotherapy and melphalan.

Authors:  N A Buskard; D A Boyes; L Grossman
Journal:  Can Med Assoc J       Date:  1977-10-08       Impact factor: 8.262

2.  Cyclophosphamide in chronic active hepatitis.

Authors:  R Althouse; J E Huff; L Tomatis; J D Wilbourn
Journal:  Br Med J       Date:  1979-06-16

3.  Visual recovery in orbital vasculitis.

Authors:  A Bagegni; R W Lyness; P B Johnston; J F Douglas
Journal:  Br J Ophthalmol       Date:  1988-10       Impact factor: 4.638

4.  The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.

Authors:  J A Baltus; J W Boersma; A P Hartman; J P Vandenbroucke
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

5.  Sister chromatid exchange analysis in monitoring chlorambucil therapy in primary nephrotic syndrome of childhood.

Authors:  A Y Elzouki; K al-Nassar; M al-Ali; G Malik; F Elsharie; O P Jaiswal
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

Review 6.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

7.  Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.

Authors:  W H Likosky; B Fireman; R Elmore; G Eno; K Gale; G B Goode; K Ikeda; J Laster; C Mosher; J Rozance
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

8.  Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.

Authors:  John H Kempen; Sapna Gangaputra; Ebenezer Daniel; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Kathy J Helzlsouer
Journal:  Am J Ophthalmol       Date:  2008-06-25       Impact factor: 5.258

9.  Acute leukemia after cytotoxic treatment for nonmalignant disease in childhood. A case report and review of the literature.

Authors:  W Müller; M Brandis
Journal:  Eur J Pediatr       Date:  1981-03       Impact factor: 3.183

10.  Proceedings of the British Association for Cancer Research. University of Glasgow 28--30 March 1979. Abstracts.

Authors: 
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.